Related Posts on Trends in Specialty and Oncology

Rachel Sliney

Cancer is a daily battle for many, and for decades chemotherapy has been the frontline’s best defense. That is changing thanks to increasing research in the fields of immunology and genetics....

Brooke Wright

 

...

Brooke Wright

Those who travel to southeast Asia will likely hear the phrase “Same Same But Different” which, among other uses, is commonly said by market vendors trying to sell a knock-off of a brand name item...

Danielle Snook

Today, Novartis officially launched the highly anticipated first U.S. biosimilar, ZARXIO. ZARXIO was approved for the...

Danielle Snook

No matter where you live, there is inevitably some type of natural disaster your community has to plan for. For instance in California, scientist warnings of the “big one” keep builders and...

Danielle Snook

There has been a lot of talk this year on the highly anticipated entry of biosimilars. With continued rising specialty and oncology drug costs, payers may utilize management...